Reader Comments (1)
Post a new comment on this article
-
0 Responses10 Aug 2012
13:44 GMT
Most RecentPublisher's Note: Errors in Affiliations Posted by PLOS_Genetics on 10 Aug 2012 at 13:44 GMT
-
Loading metrics
Open Access
Peer-reviewed
Research Article
GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers
-
Shengping Li ,
Contributed equally to this work with: Shengping Li, Ji Qian, Yuan Yang
Affiliation Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯ -
Ji Qian ,
Contributed equally to this work with: Shengping Li, Ji Qian, Yuan Yang
Affiliation State Key Laboratory of Genetic Engineering, Center for Fudan–VARI Genetic Epidemiology and MOE Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, China
⨯ -
Yuan Yang ,
Contributed equally to this work with: Shengping Li, Ji Qian, Yuan Yang
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ -
Wanting Zhao,
Affiliation Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore
⨯ -
Juncheng Dai,
Affiliation MOE Key Laboratory of Modern Toxicology, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention, and Treatment, and State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China
⨯ -
Jin-Xin Bei,
Affiliation Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯ -
Jia Nee Foo,
Affiliation Division of Genetics, Brigham and Women's Hospital, Harvard Medical School Boston and Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America
⨯ -
Paul J. McLaren,
Affiliation Division of Genetics, Brigham and Women's Hospital, Harvard Medical School Boston and Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America
⨯ -
Zhiqiang Li,
Affiliation Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China
⨯ -
Jingmin Yang,
Affiliation State Key Laboratory of Genetic Engineering, Center for Fudan–VARI Genetic Epidemiology and MOE Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, China
⨯ -
Feng Shen,
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ -
Li Liu,
Affiliation Department of Hepatobiliary Surgery, Nantong Tumor Hospital, Nantong, China
⨯ -
Jiamei Yang,
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ -
Shuhong Li,
Affiliation Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯ -
Shandong Pan,
Affiliation MOE Key Laboratory of Modern Toxicology, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention, and Treatment, and State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China
⨯ -
Yi Wang,
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ -
Wenjin Li,
Affiliation Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China
⨯ -
Xiangjun Zhai,
Affiliation Department of Infection Diseases, Jiangsu Province Center for Disease Prevention and Control, Nanjing, China
⨯ -
Boping Zhou,
Affiliation The Third People's Municipal Hospital of Shenzhen, Shenzhen, China
⨯ -
Lehua Shi,
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ -
Xinchun Chen,
Affiliation The Third People's Municipal Hospital of Shenzhen, Shenzhen, China
⨯ -
Minjie Chu,
Affiliation MOE Key Laboratory of Modern Toxicology, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention, and Treatment, and State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China
⨯ -
Yiqun Yan,
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ -
Jun Wang,
Affiliation Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯ -
Shuqun Cheng,
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ -
Jiawei Shen,
Affiliation Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China
⨯ -
Weihua Jia,
Affiliation Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯ -
Jibin Liu,
Affiliation Department of Hepatobiliary Surgery, Nantong Tumor Hospital, Nantong, China
⨯ -
Jiahe Yang,
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ -
Zujia Wen,
Affiliation Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China
⨯ -
Aijun Li,
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ -
Ying Zhang,
Affiliation Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯ -
Guoliang Zhang,
Affiliation The Third People's Municipal Hospital of Shenzhen, Shenzhen, China
⨯ -
Xianrong Luo,
Affiliation No. 458 Hospital of Chinese People's Liberation Army, Guangzhou, China
⨯ -
Hongbo Qin,
Affiliation The Eighth Municipal People's Hospital of Guangzhou, Guangzhou, China
⨯ -
Minshan Chen,
Affiliation Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯ -
Hua Wang,
Affiliation Department of Infection Diseases, Jiangsu Province Center for Disease Prevention and Control, Nanjing, China
⨯ -
Li Jin,
Affiliation State Key Laboratory of Genetic Engineering, Center for Fudan–VARI Genetic Epidemiology and MOE Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, China
⨯ -
Dongxin Lin,
Affiliation State Key Laboratory of Molecular Oncology and Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
⨯ -
Hongbing Shen,
Affiliation MOE Key Laboratory of Modern Toxicology, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention, and Treatment, and State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China
⨯ -
Lin He,
Affiliations Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China, Institutes for Nutritional Sciences, Shanghai Institute of Biological Sciences, Chinese Academy of Sciences, Shanghai, China, Institutes of Biomedical Sciences, Fudan University, Shanghai, China
⨯ -
Paul I. W. de Bakker,
Affiliation Division of Genetics, Brigham and Women's Hospital, Harvard Medical School Boston and Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America
⨯ -
Hongyang Wang,
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ -
Yi-Xin Zeng,
Affiliation Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯ -
Mengchao Wu,
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ -
Zhibin Hu ,
* E-mail: ehphwp@126.com (W Zhou); liuj3@gis.a-star.edu.sg (J Liu); shiyongyong@gmail.com (Y Shi); zhibin_hu@njmu.edu.cn (Z Hu)
Affiliation MOE Key Laboratory of Modern Toxicology, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention, and Treatment, and State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China
⨯ -
Yongyong Shi ,
* E-mail: ehphwp@126.com (W Zhou); liuj3@gis.a-star.edu.sg (J Liu); shiyongyong@gmail.com (Y Shi); zhibin_hu@njmu.edu.cn (Z Hu)
Affiliation Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China
⨯ -
Jianjun Liu ,
* E-mail: ehphwp@126.com (W Zhou); liuj3@gis.a-star.edu.sg (J Liu); shiyongyong@gmail.com (Y Shi); zhibin_hu@njmu.edu.cn (Z Hu)
Affiliation Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore
⨯ - [ ... ],
-
Weiping Zhou
* E-mail: ehphwp@126.com (W Zhou); liuj3@gis.a-star.edu.sg (J Liu); shiyongyong@gmail.com (Y Shi); zhibin_hu@njmu.edu.cn (Z Hu)
Affiliation Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
⨯ - [ view all ]
- [ view less ]
GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers
- Shengping Li,
- Ji Qian,
- Yuan Yang,
- Wanting Zhao,
- Juncheng Dai,
- Jin-Xin Bei,
- Jia Nee Foo,
- Paul J. McLaren,
- Zhiqiang Li,
- Jingmin Yang
x
- Published: July 12, 2012
- https://doi.org/10.1371/journal.pgen.1002791